![UP6 UP6](https://data.pdbj.org/pdbjplus/data/cc/svg/UP6.svg) | UP6 | Name: | 6-AZA URIDINE 5'-MONOPHOSPHATE | Formula: | C8 H12 N3 O9 P | SMILES: | O=C1N(N=CC(=O)N1)C2OC(C(O)C2O)COP(=O)(O)O | InChi: | InChI=1S/C8H12N3O9P/c12-4-1-9-11(8(15)10-4)7-6(14)5(13)3(20-7)2-19-21(16,17)18/h1,3,5-7,13-14H,2H2,(H,10,12,15)(H2,16,17,18)/t3-,5-,6-,7-/m1/s1 | Synonyms: | 6-AZA-UMP | Definition date: | 2000-02-02 | Last modified: | 2020-06-17 | Identifier: | 2-(5-O-phosphono-beta-D-ribofuranosyl)-1,2,4-triazine-3,5(2H,4H)-dione |
|
![UPF UPF](https://data.pdbj.org/pdbjplus/data/cc/svg/UPF.svg) | UPF | Name: | URIDINE-5'-DIPHOSPHATE-2-DEOXY-2-FLUOROGALACTOSE | Formula: | C15 H23 F N2 O16 P2 | SMILES: | O=P(OC1OC(C(O)C(O)C1F)CO)(O)OP(=O)(O)OCC3OC(N2C=CC(=O)NC2=O)C(O)C3O | InChi: | InChI=1S/C15H23FN2O16P2/c16-8-11(23)9(21)5(3-19)32-14(8)33-36(28,29)34-35(26,27)30-4-6-10(22)12(24)13(31-6)18-2-1-7(20)17-15(18)25/h1-2,5-6,8-14,19,21-24H,3-4H2,(H,26,27)(H,28,29)(H,17,20,25)/t5-,6-,8-,9+,10-,11-,12-,13-,14-/m1/s1 | Synonyms: | URIDINE-5'-MONOPHOSPHATE 2-DEOXY-2-FLUORO-GALACTOPYRANOSYL-MONOPHOSPHATE ESTER | Definition date: | 2000-11-30 | Last modified: | 2020-06-17 | Identifier: | [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3R,4S,5R,6R)-3-fluoro-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl dihydrogen diphosphate (non-preferred name) |
|
![UPL UPL](https://data.pdbj.org/pdbjplus/data/cc/svg/UPL.svg) | UPL | Name: | UNKNOWN BRANCHED FRAGMENT OF PHOSPHOLIPID | Formula: | C34 H70 | SMILES: | C(CCCCCCCC(CCCCCCCCC)CCCCCCCCCCC)CCCCC | InChi: | InChI=1S/C34H70/c1-4-7-10-13-16-18-19-21-24-27-30-33-34(31-28-25-22-15-12-9-6-3)32-29-26-23-20-17-14-11-8-5-2/h34H,4-33H2,1-3H3 | Synonyms: | UNKNOWN PHOSPHOLIPID FRAGMENT | Definition date: | 2002-06-13 | Last modified: | 2020-06-17 | Identifier: | 12-nonylpentacosane |
|
![UQ8 UQ8](https://data.pdbj.org/pdbjplus/data/cc/svg/UQ8.svg) | UQ8 | Name: | Ubiquinone-8 | Formula: | C49 H74 O4 | SMILES: | O=C1C(=C(C(=O)C(OC)=C1OC)C)CC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)C | InChi: | InChI=1S/C49H74O4/c1-36(2)20-13-21-37(3)22-14-23-38(4)24-15-25-39(5)26-16-27-40(6)28-17-29-41(7)30-18-31-42(8)32-19-33-43(9)34-35-45-44(10)46(50)48(52-11)49(53-12)47(45)51/h20,22,24,26,28,30,32,34H,13-19,21,23,25,27,29,31,33,35H2,1-12H3/b37-22+,38-24+,39-26+,40-28+,41-30+,42-32+,43-34+ | Synonyms: | 2,3-dimethoxy-5-methyl-6-[(6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-oc
taen-1-yl]cyclohexa-2,5-diene-1,4-dione | Definition date: | 2008-08-21 | Last modified: | 2020-06-17 | Identifier: | 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl]cyclohexa-2,5-diene-1,4-dione |
|
![UQ9 UQ9](https://data.pdbj.org/pdbjplus/data/cc/svg/UQ9.svg) | UQ9 | Name: | Ubiquinone-9 | Formula: | C54 H82 O4 | SMILES: | O=C1C(=C(C(=O)C(OC)=C1OC)C)CC=C(/C)CCC=C(/C)CCC=C(/C)CC/C=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CC/C=C(/C)CCC=C(/C)C | InChi: | InChI=1S/C54H82O4/c1-40(2)22-14-23-41(3)24-15-25-42(4)26-16-27-43(5)28-17-29-44(6)30-18-31-45(7)32-19-33-46(8)34-20-35-47(9)36-21-37-48(10)38-39-50-49(11)51(55)53(57-12)54(58-13)52(50)56/h22,24,26,28,30,32,34,36,38H,14-21,23,25,27,29,31,33,35,37,39H2,1-13H3/b41-24-,42-26+,43-28+,44-30+,45-32-,46-34+,47-36+,48-38+ | Synonyms: | 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14Z,18E,22E,26E,30Z)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18
,22,26,30,34-nonaen-1-yl]cyclohexa-2,5-diene-1,4-dione | Definition date: | 2009-06-25 | Last modified: | 2020-06-17 | Identifier: | 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14Z,18E,22E,26E,30Z)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]cyclohexa-2,5-diene-1,4-dione |
|
![URB URB](https://data.pdbj.org/pdbjplus/data/cc/svg/URB.svg) | URB | Name: | 5-bromopyrimidine-2,4(1H,3H)-dione | Formula: | C4 H3 Br N2 O2 | SMILES: | BrC1=CNC(=O)NC1=O | InChi: | InChI=1S/C4H3BrN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9) | Synonyms: | 5-bromouracil | Definition date: | 2008-04-25 | Last modified: | 2020-06-17 | Identifier: | 5-bromopyrimidine-2,4(1H,3H)-dione |
|
![URM URM](https://data.pdbj.org/pdbjplus/data/cc/svg/URM.svg) | URM | Name: | (((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)methyl)phosphonic
(((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphoric)
anhydride | Formula: | C16 H26 N2 O16 P2 | SMILES: | OC[CH]1O[CH](C[P](O)(=O)O[P](O)(=O)OC[CH]2O[CH]([CH](O)[CH]2O)N3C=CC(=O)NC3=O)[CH](O)[CH](O)[CH]1O | InChi: | InChI=1S/C16H26N2O16P2/c19-3-6-10(21)13(24)12(23)8(32-6)5-35(27,28)34-36(29,30)31-4-7-11(22)14(25)15(33-7)18-2-1-9(20)17-16(18)26/h1-2,6-8,10-15,19,21-25H,3-5H2,(H,27,28)(H,29,30)(H,17,20,26)/t6-,7-,8-,10+,11-,12+,13+,14-,15-/m1/s1 | Synonyms: | Uridine diphospho methylene galactopyranose | Definition date: | 2010-04-14 | Last modified: | 2020-06-17 | Identifier: | [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phosphinic acid |
|
![URN URN](https://data.pdbj.org/pdbjplus/data/cc/svg/URN.svg) | URN | Name: | 5,6-DIAMINOPYRIMIDINE-2,4(1H,3H)-DIONE | Formula: | C4 H6 N4 O2 | SMILES: | O=C1NC(N)=C(N)C(=O)N1 | InChi: | InChI=1S/C4H6N4O2/c5-1-2(6)7-4(10)8-3(1)9/h5H2,(H4,6,7,8,9,10) | Synonyms: | 5,6-DIAMINOURACIL | Definition date: | 2004-11-02 | Last modified: | 2020-06-17 | Identifier: | 5,6-diaminopyrimidine-2,4(1H,3H)-dione |
|
![UU3 UU3](https://data.pdbj.org/pdbjplus/data/cc/svg/UU3.svg) | UU3 | Name: | (5R)-5-[(1S)-1,2-bis(oxidanyl)ethyl]oxolane-2,3,4-trione | Formula: | C6 H6 O6 | SMILES: | O=C1C(=O)OC(C1=O)C(O)CO | InChi: | InChI=1S/C6H6O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-8H,1H2/t2-,5+/m0/s1 | Synonyms: | Dehydroascorbic Acid | Definition date: | 2014-10-15 | Last modified: | 2020-06-17 | Release date: | 2017-03-22 | Identifier: | (5R)-5-[(1S)-1,2-dihydroxyethyl]furan-2,3,4(5H)-trione (non-preferred name) |
|
![V35 V35](https://data.pdbj.org/pdbjplus/data/cc/svg/V35.svg) | V35 | Name: | D-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID | Formula: | C10 H14 B Cl N O4 | SMILES: | Clc1ccc(cc1)CC(NC(=O)C)[B-](O)(O)O | InChi: | InChI=1S/C10H14BClNO4/c1-7(14)13-10(11(15,16)17)6-8-2-4-9(12)5-3-8/h2-5,10,15-17H,6H2,1H3,(H,13,14)/q-1/t10-/m1/s1 | Synonyms: | D-PARA-CHLORO-1-ACETAMIDO BORONIC ACID | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | [(1S)-1-(acetylamino)-2-(4-chlorophenyl)ethyl](trihydroxy)borate(1-) |
|
![V36 V36](https://data.pdbj.org/pdbjplus/data/cc/svg/V36.svg) | V36 | Name: | L-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID | Formula: | C10 H14 B Cl N O4 | SMILES: | Clc1ccc(cc1)CC(NC(=O)C)[B-](O)(O)O | InChi: | InChI=1S/C10H14BClNO4/c1-7(14)13-10(11(15,16)17)6-8-2-4-9(12)5-3-8/h2-5,10,15-17H,6H2,1H3,(H,13,14)/q-1/t10-/m0/s1 | Synonyms: | L-PARA-CHLORO-1-ACETAMIDO BORONIC ACID | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | [(1R)-1-(acetylamino)-2-(4-chlorophenyl)ethyl](trihydroxy)borate(1-) |
|
![VA1 VA1](https://data.pdbj.org/pdbjplus/data/cc/svg/VA1.svg) | VA1 | Name: | {5-[(DIFORMYLAMINO)METHYL]-1-BENZOTHIEN-2-YL}BORONIC ACID | Formula: | C11 H10 B N O4 S | SMILES: | O=CN(C=O)Cc2cc1c(sc(c1)B(O)O)cc2 | InChi: | InChI=1S/C11H10BNO4S/c14-6-13(7-15)5-8-1-2-10-9(3-8)4-11(18-10)12(16)17/h1-4,6-7,16-17H,5H2 | Synonyms: | 5-DIFORMYLAMINOMETHYL-BENZO[B]THIOPHEN-2-BORONIC ACID | Definition date: | 2006-09-01 | Last modified: | 2020-06-17 | Identifier: | {5-[(diformylamino)methyl]-1-benzothiophen-2-yl}boronic acid |
|
![VAK VAK](https://data.pdbj.org/pdbjplus/data/cc/svg/VAK.svg) | VAK | Name: | methyl (1R,2R,4S)-2-ethyl-2,4,5,7-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate | Formula: | C22 H20 O8 | SMILES: | O=C(OC)C4c2c(c(O)c1C(=O)c3c(C(=O)c1c2)cccc3O)C(O)CC4(O)CC | InChi: | InChI=1S/C22H20O8/c1-3-22(29)8-13(24)15-10(17(22)21(28)30-2)7-11-16(20(15)27)19(26)14-9(18(11)25)5-4-6-12(14)23/h4-7,13,17,23-24,27,29H,3,8H2,1-2H3/t13-,17-,22+/m0/s1 | Synonyms: | Aklavinone | Definition date: | 2009-07-31 | Last modified: | 2020-06-17 | Identifier: | methyl (1R,2R,4S)-2-ethyl-2,4,5,7-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate |
|
![VBN VBN](https://data.pdbj.org/pdbjplus/data/cc/svg/VBN.svg) | VBN | Name: | (4S,5R)-N-{3-[(2,3-dihydroxybenzoyl)amino]propyl}-2-(2,3-dihydroxyphenyl)-N-[3-({[(4S,5R)-2-(2,3-dihydroxyphenyl)-5-met
hyl-4,5-dihydro-1,3-oxazol-4-yl]carbonyl}amino)propyl]-5-methyl-4,5-dihydro-1,3-oxazole-4-carboxamide | Formula: | C35 H39 N5 O11 | SMILES: | O=C(N(CCCNC(=O)c1cccc(O)c1O)CCCNC(=O)C2N=C(OC2C)c3cccc(O)c3O)C4N=C(OC4C)c5cccc(O)c5O | InChi: | InChI=1S/C35H39N5O11/c1-18-26(38-33(50-18)21-9-4-12-24(42)29(21)45)32(48)37-15-7-17-40(16-6-14-36-31(47)20-8-3-11-23(41)28(20)44)35(49)27-19(2)51-34(39-27)22-10-5-13-25(43)30(22)46/h3-5,8-13,18-19,26-27,41-46H,6-7,14-17H2,1-2H3,(H,36,47)(H,37,48)/t18-,19-,26+,27+/m1/s1 | Synonyms: | vibriobactin | Definition date: | 2011-04-06 | Last modified: | 2020-06-17 | Identifier: | (4S,5R)-N-{3-[(2,3-dihydroxybenzoyl)amino]propyl}-2-(2,3-dihydroxyphenyl)-N-[3-({[(4S,5R)-2-(2,3-dihydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]carbonyl}amino)propyl]-5-methyl-4,5-dihydro-1,3-oxazole-4-carboxamide |
|
![VBP VBP](https://data.pdbj.org/pdbjplus/data/cc/svg/VBP.svg) | VBP | Name: | 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid | Formula: | C15 H15 N3 O6 | SMILES: | O=C(O)c1ccc(cc1)CN2C(=O)C=CN(C2=O)CC(N)C(=O)O | InChi: | InChI=1S/C15H15N3O6/c16-11(14(22)23)8-17-6-5-12(19)18(15(17)24)7-9-1-3-10(4-2-9)13(20)21/h1-6,11H,7-8,16H2,(H,20,21)(H,22,23)/t11-/m1/s1 | Synonyms: | (S)-1-(2-amino-2-carboxyethyl)-3-(4-carboxybenzyl)pyrimidine-2,4-dione | Definition date: | 2009-04-09 | Last modified: | 2020-06-17 | Identifier: | 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid |
|
![VD1 VD1](https://data.pdbj.org/pdbjplus/data/cc/svg/VD1.svg) | VD1 | Name: | 5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL | Formula: | C23 H36 O2 | SMILES: | OC3C(=C)C(O)CC(=CC=C1/CCCC2(C1CCC2C(C)CC)C)C3 | InChi: | InChI=1S/C23H36O2/c1-5-15(2)19-10-11-20-18(7-6-12-23(19,20)4)9-8-17-13-21(24)16(3)22(25)14-17/h8-9,15,19-22,24-25H,3,5-7,10-14H2,1-2,4H3/b18-9+/t15-,19+,20-,21+,22+,23+/m0/s1 | Synonyms: | 1-ALPHA-HYDROXY-2-METHYLENE-19-NOR-(20S)-BISHOMOPREGNACALCIFEROL | Definition date: | 2003-12-17 | Last modified: | 2020-06-17 | Identifier: | (1R,3R,7E,17beta)-2-methylidene-17-[(1S)-1-methylpropyl]-9,10-secoestra-5,7-diene-1,3-diol |
|
![VD2 VD2](https://data.pdbj.org/pdbjplus/data/cc/svg/VD2.svg) | VD2 | Name: | 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYL-CYCLOHEXANE-1,3-DIOL | Formula: | C27 H46 O3 | SMILES: | OC3CC(=C/C=C1CCCC2(C)C(C(C)CCCC(O)(C)C)CCC12)CC(O)C3C | InChi: | InChI=1S/C27H46O3/c1-18(8-6-14-26(3,4)30)22-12-13-23-21(9-7-15-27(22,23)5)11-10-20-16-24(28)19(2)25(29)17-20/h10-11,18-19,22-25,28-30H,6-9,12-17H2,1-5H3/b20-10-,21-11+/t18-,19+,22-,23+,24-,25-,27-/m1/s1 | Synonyms: | 2-ALPHA-METHYL-19-NOR-1,25-DIHYDROXYVITAMIN D3 | Definition date: | 2003-12-17 | Last modified: | 2020-06-17 | Identifier: | (1R,2R,3R,5E,7E,17beta)-17-[(1R)-5-hydroxy-1,5-dimethylhexyl]-2-methyl-9,10-secoestra-5,7-diene-1,3-diol |
|
![VD3 VD3](https://data.pdbj.org/pdbjplus/data/cc/svg/VD3.svg) | VD3 | Name: | (1S,3Z)-3-[(2E)-2-[(1R,3AR,7AS)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLI
DENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL | Formula: | C27 H44 O | SMILES: | OC3CC(=C/C=C1CCCC2(C)C(C(C)CCCC(C)C)CCC12)C(=C)CC3 | InChi: | InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/t21-,24+,25-,26+,27-/m1/s1 | Synonyms: | VITAMIN D3 | Definition date: | 2006-06-15 | Last modified: | 2020-06-17 | Identifier: | (3S,5E,7Z,14beta,17alpha)-9,10-secocholesta-5,7,10-trien-3-ol |
|
![VDN VDN](https://data.pdbj.org/pdbjplus/data/cc/svg/VDN.svg) | VDN | Name: | 2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE | Formula: | C23 H32 N6 O4 S | SMILES: | O=C2N=C(Nn1c(nc(c12)C)CCC)c3cc(ccc3OCC)S(=O)(=O)N4CCN(CC)CC4 | InChi: | InChI=1S/C23H32N6O4S/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30) | Synonyms: | VARDENAFIL, LEVITRA | Definition date: | 2003-07-10 | Last modified: | 2020-06-17 | Identifier: | 2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one |
|
![VDZ VDZ](https://data.pdbj.org/pdbjplus/data/cc/svg/VDZ.svg) | VDZ | Name: | 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIO
L | Formula: | C27 H44 O3 | SMILES: | OC3/C(=C)C(O)CC(=CC=C1/CCCC2(C1CCC2C(C)CCCC(O)(C)C)C)C3 | InChi: | InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)22-12-13-23-21(9-7-15-27(22,23)5)11-10-20-16-24(28)19(2)25(29)17-20/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b21-11+/t18-,22+,23-,24+,25+,27+/m0/s1 | Synonyms: | 2-METHYLENE-19-NOR-(20S)-1ALPHA,25-DIHYDROXY-VITAMIN D3 | Definition date: | 2003-12-17 | Last modified: | 2020-06-17 | Identifier: | (1R,3R,7E,17beta)-17-[(1S)-5-hydroxy-1,5-dimethylhexyl]-2-methylidene-9,10-secoestra-5,7-diene-1,3-diol |
|
![VGH VGH](https://data.pdbj.org/pdbjplus/data/cc/svg/VGH.svg) | VGH | Name: | 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine | Formula: | C21 H22 Cl2 F N5 O | SMILES: | Clc1ccc(F)c(Cl)c1C(Oc2cc(cnc2N)c3cnn(c3)C4CCNCC4)C | InChi: | InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1 | Synonyms: | CRIZOTINIB | Definition date: | 2009-04-20 | Last modified: | 2020-06-17 | Identifier: | 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine |
|
![VHS VHS](https://data.pdbj.org/pdbjplus/data/cc/svg/VHS.svg) | VHS | Name: | 3-[(1S)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY]-5-(1-PIPERIDIN-4-YLPYRAZOL-4-YL)PYRIDIN-2-AMINE | Formula: | C21 H22 Cl2 F N5 O | SMILES: | Clc1ccc(F)c(Cl)c1C(Oc4cc(c2cn(nc2)C3CCNCC3)cnc4N)C | InChi: | InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m0/s1 | Synonyms: | S-CRIZOTINIB | Definition date: | 2013-10-03 | Last modified: | 2020-06-17 | Release date: | 2014-04-02 | Identifier: | 3-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine |
|
![VIT VIT](https://data.pdbj.org/pdbjplus/data/cc/svg/VIT.svg) | VIT | Name: | VITAMIN E | Formula: | C29 H50 O2 | SMILES: | Oc2c(c(c1OC(CCc1c2C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)C | InChi: | InChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m0/s1 | Synonyms: | 2,5,7,8-TETRAMETHYL-2-(4,8,12-TRIMETHYLTRIDECYL)-6-CHROMANOL | Definition date: | 2000-08-02 | Last modified: | 2020-06-17 | Identifier: | (2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol |
|
![VK3 VK3](https://data.pdbj.org/pdbjplus/data/cc/svg/VK3.svg) | VK3 | Name: | MENADIONE | Formula: | C11 H8 O2 | SMILES: | O=C2c1c(cccc1)C(=O)C(=C2)C | InChi: | InChI=1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3 | Synonyms: | VITAMIN K3 | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | 2-methylnaphthalene-1,4-dione |
|
![VLB VLB](https://data.pdbj.org/pdbjplus/data/cc/svg/VLB.svg) | VLB | Name: | (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE | Formula: | C46 H58 N4 O9 | SMILES: | O=C(OC)C4(c2c(c1ccccc1n2)CCN3CC(O)(CC)CC(C3)C4)c5c(OC)cc6c(c5)C89C(N6C)C(O)(C(=O)OC)C(OC(=O)C)C7(C=CCN(C78)CC9)CC | InChi: | InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1 | Synonyms: | VINBLASTINE | Definition date: | 2005-03-17 | Last modified: | 2020-06-17 | Identifier: | (2alpha,2'beta,3alpha,5beta,19beta)-vincaleukoblastine |
|